Clinical Trials Directory

Trials / Sponsors / Mural Oncology, Inc

Mural Oncology, Inc

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
TerminatedPhase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithe
Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Phase 32022-01-10
TerminatedNemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Muco
Cutaneous Melanoma, Mucosal Melanoma
Phase 22021-09-27
Active Not RecruitingLess Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and i
Advanced Solid Tumor
Phase 1 / Phase 22020-09-30
CompletedA Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 22020-02-05
CompletedA Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Al
Advanced Solid Tumors
Phase 1 / Phase 22019-02-26
CompletedA Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors
Advanced Solid Tumors
Phase 1 / Phase 22016-09-14